awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34807860-3D44E781-1F09-46E8-85C2-B54E7ADE923D
Q34807860-3D44E781-1F09-46E8-85C2-B54E7ADE923D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34807860-3D44E781-1F09-46E8-85C2-B54E7ADE923D
Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways
P2860
Q34807860-3D44E781-1F09-46E8-85C2-B54E7ADE923D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34807860-3D44E781-1F09-46E8-85C2-B54E7ADE923D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d6ab69db1a90cf21ad4c9024d4047d3b85740d73
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.